Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.21.2
Net Loss Per Share (Tables)
6 Months Ended
Jun. 30, 2021
Net Loss Per Share  
Schedule for Net Loss Per Share

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2021

 

 

2020

 

 

2021

 

 

2020

 

Basic

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$ (1,801,818 )

 

$ (2,315,638 )

 

$ (4,002,729 )

 

$ (4,759,952 )

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

6,595,483

 

 

 

3,486,566

 

 

 

6,592,454

 

 

 

3,390,782

 

Basic net loss per share

 

$ (0.27 )

 

$ (0.66 )

 

$ (0.61 )

 

 

(1.40 )

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss attributable to common stockholders, basic

 

$ (1,801,818 )

 

$ (2,315,638 )

 

$ (4,002,729 )

 

$ (4,759,952 )

Effect of dilutive securities

 

 

 

 

 

 

 

 

 

 

 

— 

 

Net loss, diluted

 

$ (1,801,818 )

 

$ (2,315,638 )

 

$ (4,002,729 )

 

$ (4,759,952 )

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding - basic

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Potential common share issuances:

 

 

6,595,483

 

 

 

3,486,566

 

 

 

6,592,454

 

 

 

3,390,782

 

Incremental dilutive shares from equity instruments (treasury stock method)

 

 

 

 

 

 

 

 

 

 

 

— 

 

Weighted-average common shares outstanding

 

 

6,595,483

 

 

 

3,486,566

 

 

 

6,592,454

 

 

 

3,390,782

 

Diluted net loss per share

 

$ (0.27 )

 

$ (0.66 )

 

$ (0.61 )

 

$ (1.40 )
Summary of diluted weighted shares outstanding

 

 

Three and Six Months Ended

 

 

 

June 30,

 

 

 

2021

 

 

2020

 

Warrants outstanding

 

 

45,577

 

 

 

70,361

 

Stock options outstanding

 

 

563,734

 

 

 

508,762

 

RSUs outstanding

 

 

243,800

 

 

 

 

Series A convertible preferred stock to common shares

 

 

80,235

 

 

 

79,744

 

Series B convertible preferred stock to common shares

 

 

281,690

 

 

 

262,805

 

Total

 

 

1,215,036

 

 

 

921,672